MedReleaf Reports Fourth Quarter and Fiscal Year 2017 Results Fiscal 2017 Adjusted EBITDA of $14 million on $40 million in sales; phase 1 Bradford Facility expansion complete and in...

Earlier this month, Tilray made a big change in how it will be marketing its medical cannabis products. Historically, it was selling its dried cannabis products under common strain names,...

In what appears to be one of the most successful cannabis industry investments to date, MedMen Opportunity Fund achieved realized and unrealized gains of about C$33.5mm on a C$10mm investment...